期刊文献+

WJSC 6^(th) Anniversary Special Issues(2):Mesenchymal stem cells Progress of mesenchymal stem cell therapy for neural and retinal diseases 被引量:13

WJSC 6^(th) Anniversary Special Issues(2):Mesenchymal stem cells Progress of mesenchymal stem cell therapy for neural and retinal diseases
下载PDF
导出
摘要 Complex circuitry and limited regenerative power make central nervous system(CNS)disorders the most challenging and difficult for functional repair.With elusive disease mechanisms,traditional surgical and medical interventions merely slow down the progression of the neurodegenerative diseases.However,the number of neurons still diminishes in many patients.Recently,stem cell therapy has been proposed as a viable option.Mesenchymal stem cells(MSCs),a widely-studied human adult stem cell population,have been discovered for more than 20 years.MSCs have been found all over the body and can be conveniently obtained from different accessible tissues:bone marrow,blood,and adipose and dental tissue.MSCs have high proliferative and differentiation abilities,providing an inexhaustible source of neurons and glia for cell replacement therapy.Moreover,MSCs also show neuroprotective effects without any genetic modification or reprogramming.In addition,the extraordinary immunomodulatory properties of MSCs enable autologous and heterologous transplantation.These qualities heighten the clinical applicability of MSCs when dealing with the pathologies of CNS disorders.Here,we summarize the latest progress of MSC experimental research as well as human clinical trials for neural and retinal diseases.This review article will focus on multiple sclerosis,spinal cord injury,autism,glaucoma,retinitis pigmentosa and age-related macular degeneration. Complex circuitry and limited regenerative power make central nervous system(CNS)disorders the most challenging and difficult for functional repair.With elusive disease mechanisms,traditional surgical and medical interventions merely slow down the progression of the neurodegenerative diseases.However,the number of neurons still diminishes in many patients.Recently,stem cell therapy has been proposed as a viable option.Mesenchymal stem cells(MSCs),a widely-studied human adult stem cell population,have been discovered for more than 20 years.MSCs have been found all over the body and can be conveniently obtained from different accessible tissues:bone marrow,blood,and adipose and dental tissue.MSCs have high proliferative and differentiation abilities,providing an inexhaustible source of neurons and glia for cell replacement therapy.Moreover,MSCs also show neuroprotective effects without any genetic modification or reprogramming.In addition,the extraordinary immunomodulatory properties of MSCs enable autologous and heterologous transplantation.These qualities heighten the clinical applicability of MSCs when dealing with the pathologies of CNS disorders.Here,we summarize the latest progress of MSC experimental research as well as human clinical trials for neural and retinal diseases.This review article will focus on multiple sclerosis,spinal cord injury,autism,glaucoma,retinitis pigmentosa and age-related macular degeneration.
出处 《World Journal of Stem Cells》 SCIE CAS 2014年第2期111-119,共9页 世界干细胞杂志(英文版)(电子版)
基金 Supported by Veterans Affairs(VA)Merit Review Grant Senior VA Research Career Scientist Award,Miami
关键词 MESENCHYMAL STEM cells STEM cell therapy CENTRAL nervous system RETINA Clinical TRIAL Mesenchymal stem cells Stem cell therapy Central nervous system Retina Clinical trial
  • 相关文献

参考文献33

  • 1霍冬梅,董方田,于伟泓,高斐.骨髓间充质干细胞在视网膜色素变性大鼠视网膜下的分化(英文)[J].国际眼科杂志,2010,10(10):1851-1854. 被引量:13
  • 2Naohisa Wada,Stan Gronthos,P. Mark Bartold.Immunomodulatory effects of stem cells[J]. Periodontol 2000 . 2013 (1)
  • 3Y. Guan,L. Cui,Z. Qu,L. Lu,F. Wang,Y. Wu,J. Zhang,F. Gao,H. Tian,L. Xu,G. Xu,W. Li,Y. Jin,G. -T. Xu.Subretinal Transplantation of Rat MSCs and Erythropoietin Gene Modified Rat MSCs for Protecting and Rescuing Degenerative Retina in Rats[J]. Current Molecular Medicine . 2013 (9)
  • 4Samad Nadri,Shahin Yazdani,Ehsan Arefian,Zahra Gohari,Mohamadreza Baghaban Eslaminejad,Bahram Kazemi,Masoud Soleimani.Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane[J]. Neuroscience Letters . 2013
  • 5Samad Nadri,Bahram Kazemi,Mohamadreza Baghaban Eeslaminejad,Shahin Yazdani,Masoud Soleimani.High yield of cells committed to the photoreceptor-like cells from conjunctiva mesenchymal stem cells on nanofibrous scaffolds[J]. Molecular Biology Reports . 2013 (6)
  • 6Travis Thompson.Autism Research and Services for Young Children: History, Progress and Challenges[J]. J Appl Res Intellect Disabil . 2013 (2)
  • 7Peter Connick,Madhan Kolappan,Charles Crawley,Daniel J Webber,Rickie Patani,Andrew W Michell,Ming-Qing Du,Shi-Lu Luan,Daniel R Altmann,Alan J Thompson,Alastair Compston,Michael A Scott,David H Miller,Siddharthan Chandran.Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study[J]. Lancet Neurology . 2012 (2)
  • 8Michael D. Carrithers.Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-Mediated Repair[J]. Current Pharmaceutical Biotechnology . 2012 (8)
  • 9Jeffery J Auletta,Amelia M Bartholomew,Richard T Maziarz,Robert J Deans,Robert H Miller,Hillard M Lazarus,Jeffrey A Cohen.The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis[J]. Immunotherapy . 2012 (5)
  • 10Mohammadali Almasieh,Ariel M. Wilson,Barbara Morquette,Jorge Luis Cueva Vargas,Adriana Di Polo.The molecular basis of retinal ganglion cell death in glaucoma[J]. Progress in Retinal and Eye Research . 2011 (2)

二级参考文献1

共引文献31

同被引文献74

引证文献13

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部